Literature DB >> 56651

Thymine-requiring bacteria associated with co-trimoxazole therapy.

R Maskell, O A Okubadejo, R H Payne.   

Abstract

Since 1971 thymine-requiring (thy-) pathogens have been isolated from the urine of 8 patients with renal calculi, and from the sputum of 1 patient with chronic chest infection. The patients had been treated with co-trimoxazole for several months before the isolation of the mutant pathogens. There was persistent pyuria in the patients with renal calculi, and purulent sputum in the patient with chronic chest infection. The mutants were identified by their inability to grow on diagnostic sensitivity test agar (D.S.T., Oxoid) which is deficient in thymine. It was found that wild-type bacteria can produce growth factors for the metabolism of the mutants in vitro, and the urine of the patients contained by thymine-like compounds. These findings indicate that thy- mutants may develop in renal calculi during co-trimoxazole therapy. Therapy should be changed to a more suitable antimicrobial as soon as possible after diagnosis of mutant infection.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 56651     DOI: 10.1016/s0140-6736(76)90482-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  6 in total

1.  Incidence of thymidine-dependent enterococci detected on Mueller-Hinton agar with low thymidine content.

Authors:  R C Haltiner; P C Migneault; R G Robertson
Journal:  Antimicrob Agents Chemother       Date:  1980-09       Impact factor: 5.191

2.  Renal stones and urinary infection: a study of antibiotic treatment.

Authors:  R H Chinn; R Maskell; J A Mead; A Polak
Journal:  Br Med J       Date:  1976-12-11

Review 3.  Trimethoprim: a review of its antibacterial activity, pharmacokinetics and therapeutic use in urinary tract infections.

Authors:  R N Brogden; A A Carmine; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1982-06       Impact factor: 9.546

Review 4.  A new look at erythromycin.

Authors:  R W Lacey
Journal:  Postgrad Med J       Date:  1977-04       Impact factor: 2.401

5.  Rifampin plus trimethoprim: bactericidal activity and suppression of resistance in human urine in vitro.

Authors:  B P Goldstein; I F Ripamonti; G Bolzoni; G Carniti; V Arioli
Journal:  Antimicrob Agents Chemother       Date:  1979-12       Impact factor: 5.191

6.  Effect of thymidine on activity of trimethoprim and sulphamethoxazole.

Authors:  A Stokes; R W Lacey
Journal:  J Clin Pathol       Date:  1978-02       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.